Preclinical Development: Overview
Clinical Trials: Overview
Drug Discovery: Overview
Drug Administration and Therapy Phases: Overview
In Vitro Drug Release Testing: Overview, Development and Validation
Drug Regulation
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
1Kimiagar Toos Pharmaceutical Company, Mashhad, Khorasan Razavi, Iran (Islamic Republic of).
这项研究开发了用于阿尔茨海默病治疗的选择性ROCK 2抑制剂. 最有选择性的化合物抑制了19激酶,显示了减少副作用的潜力.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
结论: